Since it has been shown that knockdown of endocan attenuate the PAH related changes in a rat model of CTD-PAH via inhibition of TNF-α related inflammation pathways [17], it could be hypothesized that endocan may participate in the pathogenesis of preeclampsia via enhancing inflammation related endothelial dysfunction. The gene discussed is ESM1; the disease is pulmonary arterial hypertension.